TY - JOUR
T1 - Disruption of the extracellular matrix progressively impairs central nervous system vascular maturation downstream of β-catenin signaling
AU - Jensen, Lasse D.
AU - Hot, Belma
AU - Ramsköld, Daniel
AU - Germano, Raoul F.V.
AU - Yokota, Chika
AU - Giatrellis, Sarantis
AU - Lauschke, Volker M.
AU - Hubmacher, Dirk
AU - Li, Minerva X.
AU - Hupe, Mike
AU - Arnold, Thomas D.
AU - Sandberg, Rickard
AU - Frisén, Jonas
AU - Trusohamn, Marta
AU - Martowicz, Agnieszka
AU - Wisniewska-Kruk, Joanna
AU - Nyqvist, Daniel
AU - Adams, Ralf H.
AU - Apte, Suneel S.
AU - Vanhollebeke, Benoit
AU - Stenman, Jan M.
AU - Kele, Julianna
N1 - Funding Information:
This work was partly supported by Cancerfonden [CAN 2010/679]. B. Hot was funded by Karolinska Funding for Doctorial Studies. L.D.E. Jensen was financially supported by the Swedish Society for Medical Research, Jeanssons Stiftelser, the Swedish Research Council and H2020-MSCA-RISE (3D-NEONET). D. Ramsköld was funded by Johnson & Johnson (K240001043). V.M. Lauschke was supported by a Marie Curie FP7 people initiative Fellowship (626544), D. Hubmacher by National Institutes of Health (AR070748), S.S. Apte by National Institutes of Health (AR53890), and D. Nyqvist by the Swedish Society for Medical Research and the Swedish Research Council. J.M. Stenman was supported by Wenner-Gren Fellows and J. Kele was funded by Swedish Society for Medical Research, Swedish Brain Foundation, Tore Nilsons Stiftelse, Tornspiran, Lars Hiertas Stiftelse, Jane and Dan Olsson Foundations, Samariten and Bergvalls Stiftelse.
Funding Information:
We thank Dr Christian G?ritz for providing reagents and animal housing, Dr Olov Andersson for providing reagents and equipment for pilot experiments, Drs Lars Jakobsson and Maarja Andaloussi M?e/Professor Christer Betsholtz for providing antibodies, Dr Kirsty Spalding for granting access to FACS and related equipment during pilot studies, Dr Douglas W. Houston (University of Iowa) for kindly providing the FLAG-axin1/pCS2+ construct, Dr Jan Mulder and Professor Peter Nilsson at SciLife Lab for input regarding antibodies from the Human Protein Atlas, Mattias Karl?n for kindly improving our illustrations and Dr Igor Adameyko and Professor Thomas Perlmann for comments on the article. This work was partly supported by Cancerfonden [CAN 2010/679]. B. Hot was funded by Karolinska Funding for Doctorial Studies. L.D.E. Jensen was financially supported by the Swedish Society for Medical Research, Jeanssons Stiftelser, the Swedish Research Council and H2020-MSCA-RISE (3D-NEONET). D. Ramsk?ld was funded by Johnson & Johnson (K240001043). V.M. Lauschke was supported by a Marie Curie FP7 people initiative Fellowship (626544), D. Hubmacher by National Institutes of Health (AR070748), S.S. Apte by National Institutes of Health (AR53890), and D. Nyqvist by the Swedish Society for Medical Research and the Swedish Research Council. J.M. Stenman was supported by Wenner-Gren Fellows and J. Kele was funded by Swedish Society for Medical Research, Swedish Brain Foundation, Tore Nilsons Stiftelse, Tornspiran, Lars Hiertas Stiftelse, Jane and Dan Olsson Foundations, Samariten and Bergvalls Stiftelse.
Publisher Copyright:
© 2019 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
PY - 2019
Y1 - 2019
N2 - Objective-The Wnt/β-catenin pathway orchestrates development of the blood-brain barrier, but the downstream mechanisms involved at different developmental windows and in different central nervous system (CNS) tissues have remained elusive. Approach and Results-Here, we create a new mouse model allowing spatiotemporal investigations of Wnt/β-catenin signaling by induced overexpression of Axin1, an inhibitor of β-catenin signaling, specifically in endothelial cells (Axin1iEC−OE). AOE (Axin1 overexpression) in Axin1iEC−OE mice at stages following the initial vascular invasion of the CNS did not impair angiogenesis but led to premature vascular regression followed by progressive dilation and inhibition of vascular maturation resulting in forebrain-specific hemorrhage 4 days post-AOE. Analysis of the temporal Wnt/β-catenin driven CNS vascular development in zebrafish also suggested that Axin1iEC−OE led to CNS vascular regression and impaired maturation but not inhibition of ongoing angiogenesis within the CNS. Transcriptomic profiling of isolated, β-catenin signaling-deficient endothelial cells during early blood-brain barrier-development (E11.5) revealed ECM (extracellular matrix) proteins as one of the most severely deregulated clusters. Among the 20 genes constituting the forebrain endothelial cell-specific response signature, 8 (Adamtsl2, Apod, Ctsw, Htra3, Pglyrp1, Spock2, Ttyh2, and Wfdc1) encoded bona fide ECM proteins. This specific β-catenin-responsive ECM signature was also repressed in Axin1iEC−OE and endothelial cell-specific β-catenin-knockout mice (Ctnnb1-KOiEC) during initial blood-brain barrier maturation (E14.5), consistent with an important role of Wnt/β-catenin signaling in orchestrating the development of the forebrain vascular ECM. Conclusions-These results suggest a novel mechanism of establishing a CNS endothelium-specific ECM signature downstream of Wnt-β-catenin that impact spatiotemporally on blood-brain barrier differentiation during forebrain vessel development.
AB - Objective-The Wnt/β-catenin pathway orchestrates development of the blood-brain barrier, but the downstream mechanisms involved at different developmental windows and in different central nervous system (CNS) tissues have remained elusive. Approach and Results-Here, we create a new mouse model allowing spatiotemporal investigations of Wnt/β-catenin signaling by induced overexpression of Axin1, an inhibitor of β-catenin signaling, specifically in endothelial cells (Axin1iEC−OE). AOE (Axin1 overexpression) in Axin1iEC−OE mice at stages following the initial vascular invasion of the CNS did not impair angiogenesis but led to premature vascular regression followed by progressive dilation and inhibition of vascular maturation resulting in forebrain-specific hemorrhage 4 days post-AOE. Analysis of the temporal Wnt/β-catenin driven CNS vascular development in zebrafish also suggested that Axin1iEC−OE led to CNS vascular regression and impaired maturation but not inhibition of ongoing angiogenesis within the CNS. Transcriptomic profiling of isolated, β-catenin signaling-deficient endothelial cells during early blood-brain barrier-development (E11.5) revealed ECM (extracellular matrix) proteins as one of the most severely deregulated clusters. Among the 20 genes constituting the forebrain endothelial cell-specific response signature, 8 (Adamtsl2, Apod, Ctsw, Htra3, Pglyrp1, Spock2, Ttyh2, and Wfdc1) encoded bona fide ECM proteins. This specific β-catenin-responsive ECM signature was also repressed in Axin1iEC−OE and endothelial cell-specific β-catenin-knockout mice (Ctnnb1-KOiEC) during initial blood-brain barrier maturation (E14.5), consistent with an important role of Wnt/β-catenin signaling in orchestrating the development of the forebrain vascular ECM. Conclusions-These results suggest a novel mechanism of establishing a CNS endothelium-specific ECM signature downstream of Wnt-β-catenin that impact spatiotemporally on blood-brain barrier differentiation during forebrain vessel development.
KW - Basement membrane
KW - Blood-brain barrier
KW - Central nervous system
KW - Embryonic development
KW - Endothelial cells
KW - Extracellular matrix
KW - Vasculature
UR - http://www.scopus.com/inward/record.url?scp=85068894784&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.119.312388
DO - 10.1161/ATVBAHA.119.312388
M3 - Article
C2 - 31242033
AN - SCOPUS:85068894784
SN - 1079-5642
VL - 39
SP - 1432
EP - 1447
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 7
ER -